Help us fund research to slow, stop and reverse Parkinson’s
The LCT programme is spearheaded by The Cure Parkinson's Trust to prioritise and fast-track drugs, currently used to treat other conditions, with the potential to slow, stop, or reverse Parkinson's. Read more
Please support the work of The Cure Parkinson's Trust. By donating today you can help us with our ground-breaking research and move us closer to finding a cure for Parkinson's. Read more
Liraglutide, Lixisenatide, Exenatide and Bydureon belong to a group of safe and well-tolerated drugs called GLP-1 agonists. They are used to treat type 2 diabetes and in recent years there has been research based evidence to suggest that they show great promise as a new treatment for Parkinson's. Read more
It has been recognised that reduced neuronal glutathione (GSH) is an early and characteristic hallmark of Parkinson’s and that reductions in glutathione lead to neuronal death. We believe that NAC increases the availability of GSH to neurons. Read more
The complete results of the GDNF trial revealed some important insights and CPT is working closely with the lead investigators to map the next steps in the development. Donations for GDNF will be held as a designated reserve until we are in a position to allocate funds to a future GDNF trial or, if no funds are allocated to a GDNF trial, we may allocate your donation to other CPT-approved research into a cure Read more
Tom Isaacs - CPT President and Co-founder - died unexpectedly on 31st May 2017. Tom was and is the charity's inspiration. His determination to help find a cure for everyone living with Parkinson’s remains the sole mission of this charity. Read more
Read more
A close relative was diagnosed with "Parky" a few years ago. Money raised to support researching a cure is a worthy and important cause to us both.
I have created a booklet to raise money for Parkinson's